US rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.
11-Jun-16
$350 million

Target:
US rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.

Acquiror:
Dr. Reddy’s Laboratories
Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 8 generic drug products to Dr. Reddy’s Laboratories